ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
-0,01%
Bitcoin
67.693,35
0,31%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Black Diamond Therapeutics Inc (BDTX)

  7. Black Diamond Therapeutics Inc (BDTX) News

BDTX

Black Diamond Therapeutics (BDTX)

Black Diamond Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BDTX
DatumZeitQuelleÜberschriftSymbolFirma
01/06/202416h00GlobeNewswire Inc.Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BDTXBlack Diamond Therapeutics Inc
29/05/202414h00GlobeNewswire Inc.Black Diamond Therapeutics to Participate in Jefferies Global Healthcare ConferenceNASDAQ:BDTXBlack Diamond Therapeutics Inc
14/05/202401h09Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BDTXBlack Diamond Therapeutics Inc
09/05/202413h30GlobeNewswire Inc.Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:BDTXBlack Diamond Therapeutics Inc
09/05/202413h13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BDTXBlack Diamond Therapeutics Inc
09/05/202413h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
24/04/202422h05GlobeNewswire Inc.Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BDTXBlack Diamond Therapeutics Inc
11/04/202414h00GlobeNewswire Inc.Black Diamond Therapeutics Announces Changes to Board of DirectorsNASDAQ:BDTXBlack Diamond Therapeutics Inc
08/04/202400h00GlobeNewswire Inc.Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual MeetingNASDAQ:BDTXBlack Diamond Therapeutics Inc
03/04/202414h00GlobeNewswire Inc.Black Diamond Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BDTXBlack Diamond Therapeutics Inc
12/03/202413h00GlobeNewswire Inc.Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:BDTXBlack Diamond Therapeutics Inc
11/03/202418h14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BDTXBlack Diamond Therapeutics Inc
05/03/202422h30GlobeNewswire Inc.Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024NASDAQ:BDTXBlack Diamond Therapeutics Inc
28/02/202414h00GlobeNewswire Inc.Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:BDTXBlack Diamond Therapeutics Inc
15/02/202423h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
15/02/202423h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
15/02/202423h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
15/02/202423h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDTXBlack Diamond Therapeutics Inc
14/02/202416h04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BDTXBlack Diamond Therapeutics Inc
18/01/202422h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
04/01/202414h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
04/01/202414h00GlobeNewswire Inc.Black Diamond Therapeutics Announces Corporate Update and Expected 2024 MilestonesNASDAQ:BDTXBlack Diamond Therapeutics Inc
13/12/202313h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
13/12/202313h00GlobeNewswire Inc.Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBMNASDAQ:BDTXBlack Diamond Therapeutics Inc
07/11/202314h00GlobeNewswire Inc.Black Diamond Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BDTXBlack Diamond Therapeutics Inc
06/11/202313h45GlobeNewswire Inc.Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:BDTXBlack Diamond Therapeutics Inc
06/11/202313h14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BDTXBlack Diamond Therapeutics Inc
06/11/202313h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDTXBlack Diamond Therapeutics Inc
14/10/202318h30GlobeNewswire Inc.Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535NASDAQ:BDTXBlack Diamond Therapeutics Inc
04/10/202318h14GlobeNewswire Inc.Black Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsNASDAQ:BDTXBlack Diamond Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BDTX

Kürzlich von Ihnen besucht

AMEX
TWH
Washtenaw
EU
MFRCC
Peoples Republic of Chin...
COIN
XFUELEUR
LSE
QJ47
Morg.st.b.v 24
TSXV
ENEV
Enerev5 Metals
ASX
A200
BetaShares Capital
LSE
QI99
Morg.st.b.v 24
USOTC
BMOOD
Blue Moon Metals (QB)
LSE
BR35
Al Rajhi Su.29
ASX
WHC
Whitehaven Coal
EU
BRAME
Madeira Bond 21 March 2035
BIT
S32562
Societe Generale Effekten
NASDAQ
AAWVSXX
Barclays Bank PLC Autoca...
EU
FCM23
Pool Flemish City Munici...
EU
XS2554746185
ING Groep International ...
NASDAQ
AAWZAXX
BMO Harris Bank NA Cappe...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten